Search research articles
Contact Us
Filters
Showing results (1-10 of 167) with videos related to
Page
of 17
Sort By:
Current Treatment Options in Cardiovascular Medicine
|
May 17, 2016
Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity
Umberto Campia, Ana Barac
Current Oncology Reports
|
April 1, 2022
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction
Irma Zhang, Ana Barac
Heart Failure Clinics
|
March 11, 2017
Cardio-oncology Related to Heart Failure: Epidermal Growth Factor Receptor Target-Based Therapy
Benjamin Kenigsberg, Varun Jain, Ana Barac
JACC. Heart Failure
|
February 8, 2018
Left Ventricular Dysfunction in Cancer Treatment: Is it Relevant?
Benjamin Kenigsberg, Anton Wellstein, Ana Barac
Case Reports in Cardiology
|
November 18, 2020
Clinical Presentations of Chagas Cardiomyopathy
Malik Shehadeh, Ana Barac, Rachel Marcus
Cardiology Clinics
|
October 8, 2019
Trastuzumab-Induced Cardiomyopathy
Rachel Barish, Emily Gates, Ana Barac
Current Cardiology Reports
|
September 16, 2022
Cardio-oncology: Implications for Clinical Practice for Women
Seyed Ebrahim Kassaian, Bhumika Gandhi, Ana Barac
Echocardiography (Mount Kisco, N.Y.)
|
September 23, 2021
Right ventricular free wall strain in acutely decompensated heart failure patients with ischemic and non-ischemic cardiomyopathy
Dino Miric, Ana Barac, Vesna Capkun, et al.
The Biochemical Journal
|
December 12, 2002
Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl
Philippe Soubeyran, Ana Barac, Iwona Szymkiewicz, et al.
Methodist Debakey Cardiovascular Journal
|
January 29, 2020
Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies
Tolulope A Agunbiade, Raja Y Zaghlol, Ana Barac
Page
of 17
Search research articles
Search
Showing results (1-10 of 167) with videos related to
Sort By:
Page
of 17
Current Treatment Options in Cardiovascular Medicine
|
May 17, 2016
Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity
Umberto Campia, Ana Barac
Current Oncology Reports
|
April 1, 2022
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction
Irma Zhang, Ana Barac
Heart Failure Clinics
|
March 11, 2017
Cardio-oncology Related to Heart Failure: Epidermal Growth Factor Receptor Target-Based Therapy
Benjamin Kenigsberg, Varun Jain, Ana Barac
JACC. Heart Failure
|
February 8, 2018
Left Ventricular Dysfunction in Cancer Treatment: Is it Relevant?
Benjamin Kenigsberg, Anton Wellstein, Ana Barac
Case Reports in Cardiology
|
November 18, 2020
Clinical Presentations of Chagas Cardiomyopathy
Malik Shehadeh, Ana Barac, Rachel Marcus
Cardiology Clinics
|
October 8, 2019
Trastuzumab-Induced Cardiomyopathy
Rachel Barish, Emily Gates, Ana Barac
Current Cardiology Reports
|
September 16, 2022
Cardio-oncology: Implications for Clinical Practice for Women
Seyed Ebrahim Kassaian, Bhumika Gandhi, Ana Barac
Echocardiography (Mount Kisco, N.Y.)
|
September 23, 2021
Right ventricular free wall strain in acutely decompensated heart failure patients with ischemic and non-ischemic cardiomyopathy
Dino Miric, Ana Barac, Vesna Capkun, et al.
The Biochemical Journal
|
December 12, 2002
Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl
Philippe Soubeyran, Ana Barac, Iwona Szymkiewicz, et al.
Methodist Debakey Cardiovascular Journal
|
January 29, 2020
Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies
Tolulope A Agunbiade, Raja Y Zaghlol, Ana Barac
Page
of 17